TRDN and catecholaminergic polymorphic ventricular tachycardia: Although there is insufficient evidence to show that there is an epidemiological predilection between different CPVT-associated mutations, the lack of reports on CALM1, CALM2, CALM3, and TRDN mutations highlights their rarity and the need to examine the global trends of genetic mutations in CPVT.